Showing results (41-50 of 104) with videos related to

Sort By:
Pageof 11
Analytica Chimica Acta|February 25, 2019
A new lysosome-targetable fluorescent probe with a large Stokes shift for detection of endogenous hydrogen polysulfides in living cellsYanshen Ren, Lulu Zhang, Ziyan Zhou, et al.
Cancer Research and Treatment|April 22, 2025
Differences in Responses to Neoadjuvant Anti-HER2 Therapy between HER2 2+ISH+ and HER2 3+ in HER2-Positive Breast CancerLingjun Ma, Ran Zheng, Lingyun Xu, et al.
Biomedicines|December 30, 2025
Early MRI-Derived Volumetric Thresholds Predict Response and Guide Personalization in HER2-Positive Breast Cancer: A Retrospective StudyHao Yao, Xuyang Qian, Ran Zheng, et al.
Cancer Epidemiology|December 17, 2013
Reproductive factors and breast cancer risk among BRCA1 or BRCA2 mutation carriers: results from ten studiesHong Pan, Zhongyuan He, Lijun Ling, et al.
Plos One|May 8, 2012
Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodesWenbin Zhou, Zhongyuan He, Jialei Xue, et al.
JBMR Plus|October 5, 2018
Sixty-Two-Year-Old Male Suffering From Uremic Leontiasis Ossea Caused by Severe Secondary HyperparathyroidismYogendranath Purrunsing, Jingjing Zhang, Ying Cui, et al.
Clinical & Experimental Metastasis|October 29, 2021
The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONOXiaoqing Shi, Xiaofeng Huang, Rui Chen, et al.
Bioorganic & Medicinal Chemistry|November 2, 2017
Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1Tianfang Ma, Fangxia Zou, Stefan Pusch, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2012
Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancerXiaofeng Chen, Xiaoming Zha, Wei Chen, et al.
Journal of Medicinal Chemistry|January 6, 2025
Discovery of 2(1H)-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient CancersChunzheng Li, Xiaojing Lan, Xinge Li, et al.
Pageof 11